PAN Liwen,DING Zhaoli,ZHAO Guigang,et al.Research Status of Dai Medicine for Treatment of Rheumatoid Arthritis[J].zhongguo zhongyiyao xinxi zazhi,2019,26(2):137-140.[doi:10.3969/j.issn.1005-5304.2019.02.032]
治疗类风湿关节炎傣药概述
- Title:
- Research Status of Dai Medicine for Treatment of Rheumatoid Arthritis
- 文章编号:
- 1005-5304(2019)02-0137-04
- Keywords:
- Dai Medicine; rheumatoid arthritis; review
- 分类号:
- R29;R274.94
- 文献标志码:
- A
- 摘要:
- 本文对傣药治疗类风湿关节炎的理论基础、单味药及复方治疗类风湿关节炎研究现况进行梳理,认为傣药治疗类风湿关节炎理论丰富,临床疗效可靠,可成为防治类风湿关节炎重要的卫生资源。目前,傣药治疗类风湿关节炎的物质基础相关研究已逐步展开,在化学成分与药理药效方面取得一些成果,初步明确了其药理机制,但在研究深度与广度上尚待加强,今后研究可从多味傣药协同治疗的机理机制方面开展。
- Abstract:
- In this article, the theoretical basis of Dai Medicine for the treatment of rheumatoid arthritis and the research status of single-medicine and compound treatment of rheumatoid arthritis were summarized. It is believed that the treatment of rheumatoid arthritis with Dai Medicine is rich in theory and reliable in clinical efficacy, and can be used as a prevention and treatment of rheumatoid arthritis. At present, the research on the material basis of the treatment of rheumatoid arthritis with Dai Medicine has been gradually carried out. Some achievements have been made in chemical composition and pharmacological efficacy, and its pharmacological mechanism has been initially clarified. However, the depth and breadth of research need to be strengthened. The research can be carried out from the mechanism of the synergistic treatment of Dai Medicine.
参考文献/References:
[1] 杨海英,苏海林,吕福聪,等.傣药黑心树中白桦脂酸的超高效液相色谱测定[J].时珍国医国药,2013,24(2):398-399.
[2] 林艳芳,玉腊波,段立刚.傣医常用名词术语解释[M].昆明:云南民族出版社,2008.
[3] 苏东敏.有毒植物薄叶山柑和苦藤的化学成分及生物活性研究[D].北京:中国协和医科大学,2007.
[4] 姜明辉,张洁,宋波,等.傣药苦藤的生药学研究[J].中国民族医药杂志,2005,11(S):69.
[5] 陈永胜,林小燕,钟林静,等.三叶蔓荆的化学成分研究[J].天然产物研究与开发,2011,23(6):1011-1013,1048.
[6] 王世平,吴艳俊,李玲,等.青牛胆化学成分的研究[J].贵阳医学院学报,2011,36(1):9-10,14.
[7] 于玲,王力川.傣药腊肠树有效成分研究[J].河北化工,2009,32(3):22-24.
[8] 王洪玲,梁文娟,钟国跃,等.腊肠树的化学成分和药理活性研究进展[J].中药材,2016,39(9):2168-2170.
[9] 郑桐,王向楠,梅之南,等.9种傣药提取物对DPPH自由基清除作用的研究[J].华中师范大学学报:自然科学版,2009,43(4):601-604.
[10] 卯明霞,彭霞,台海川,等.傣药哈宾蒿(白花臭牡丹根)生药学研究[J].中国民族医药杂志,2012,18(11):41-43.
[11] 张贵杰,代禄梅,张斌,等.臭牡丹的化学成分研究[J].中国中药杂志,2017,42(12):4788-4793.
[12] 刘林生,方功,王定勇.大叶钩藤叶子化学成分研究[J].亚太传统医药,2014,10(21):10-12.
[13] 杨君,宋纯清,胡之璧.大叶钩藤的化学成分研究[J].中国中药杂志, 2000,25(8):484.
[14] KANG T H, MURAKAMI Y, TAKAYAMA H,et al. Protective effect of Rhynchophylline and Isorhynchophylline on in vitro ischemia - induced neuronal damage in the hippocampus:putative neurotransmitter receptors involved in their action [J]. Life Sciences,2004,76(3):331-343.
[15] SHYU M H, KAO T C, YEN G C. Oleanolic acid and ursolic acid induce apoptosis in HuH7 human hepatocellular carcinoma cells through a mitochondrial-dependent pathway and downregulation of XIAP[J]. J Agric Food Chem,2010,58(10):6110-6118.
[16] YU Y X, GU Z L, YIN J L, et al. Ursolic acid induces human hepatomacell line SMMC-7721 apoptosis via p53-dependent pathway[J]. Chin Med J(Engl),2010,123(14):1915-1923.
[17] 刘清清,戴荣继,吕芳,等.傣药百样解的化学成分及药理作用研究进展[J].中国现代应用药学,2017,34(4):618-623.
[18] 韦阳连,袁志永,余金昌.竹叶兰最新研究进展[J].天津农业科学, 2016,22(7):147-150.
[19] 潘立文,王晓明,杨先振,等.名老傣医康朗香诊治类风湿关节炎的经验探析[J].浙江中医药大学学报,2016,40(8):616-621.
[20] 黄勇,岩罕金.名傣医康朗香治疗风湿病的经验[J].中国民族医药杂志,2008,14(10):20-21.
[21] 康朗仑.竹楼医述[M].昆明:云南民族出版社,2003:51.
[22] 玉腊波.傣中西医结合治疗类风湿关节炎的临床研究[J].中国民族医药杂志,2008,14(2):9-13.
[23] 林艳芳,依专,玉腊波.傣医诊断学[M].昆明:云南民族出版社, 2003:26-31.
[24] 林艳芳,玉腊波,依专.风病条辨译注[M].昆明:云南民族出版社, 2003:17-19.
[25] 康朗腊.档哈雅龙[M].昆明:云南民族出版社,2003:540-543.
相似文献/References:
[1]白云静,申洪波,孟庆刚.基于共轭梯度下降算法的类风湿关节炎BP神经网络证候模型研究[J].中国中医药信息杂志,2010,17(3):96.
[J].zhongguo zhongyiyao xinxi zazhi,2010,17(2):96.
[2]黄清春,储永良,接力刚,等.通痹灵对类风湿关节炎滑膜细胞血管内皮生长因子mRNA的影响[J].中国中医药信息杂志,2009,16(2):34.
HUANG Qing-chun,CHU Yong-liang,JIE Li-gang,et al.Effect of Tongbiling on VEGF mRNA Expression in Rheumatoid Arthritis Synovial Cell[J].zhongguo zhongyiyao xinxi zazhi,2009,16(2):34.
[3]贠明东,熊娜,王政於,等.类风湿关节炎阴虚辨证思路[J].中国中医药信息杂志,2010,17(10):91.[doi:10.3969/j.issn.1005-5304.2010.10.050]
[J].zhongguo zhongyiyao xinxi zazhi,2010,17(2):91.[doi:10.3969/j.issn.1005-5304.2010.10.050]
[4]刘怀珍,张皖东,潘喻珍,等.中药配合激素治疗类风湿关节炎60例临床观察[J].中国中医药信息杂志,2009,16(7):65.
[J].zhongguo zhongyiyao xinxi zazhi,2009,16(2):65.
[5]张永生,柴欣楼.中医药治疗类风湿关节炎临床研究概况[J].中国中医药信息杂志,2009,16(11):99.
[J].zhongguo zhongyiyao xinxi zazhi,2009,16(2):99.
[6]黄闰月,黄清春,沈鹰.复方丹参注射液对类风湿关节炎基因表达影响研究可行性探讨[J].中国中医药信息杂志,2008,15(1):91.
[J].zhongguo zhongyiyao xinxi zazhi,2008,15(2):91.
[7]王希民,刘维.白芍总苷联合维生素D3对类风湿关节炎患者血清中IFN-γ和IL-10的影响[J].中国中医药信息杂志,2008,15(7):15.
WANG Xi-min,LIU Wei.Effects of Total Glucosides of Paeony Combined with Vitamin D3 on Serum Levels of IFN-γ and IL-10 in RA Patients[J].zhongguo zhongyiyao xinxi zazhi,2008,15(2):15.
[8]赵钟文,吴宽裕,乐宇民,等.扶脾养胃法治疗急性类风湿关节炎临床研究[J].中国中医药信息杂志,2008,15(7):61.
[J].zhongguo zhongyiyao xinxi zazhi,2008,15(2):61.
[9]刘健,纵瑞凯,余学芳,等.新风胶囊对活动期类风湿关节炎患者P-选择素、血小板参数及超微结构的影响[J].中国中医药信息杂志,2008,15(9):5.
LIU Jian,ZONG Rui-kai,YU Xue-fang,et al.Effects of Xinfeng Capsule on CD62P, Platelet Parameters and Ultrastructure of Rheumatoid Arthritis Patients in Active phase[J].zhongguo zhongyiyao xinxi zazhi,2008,15(2):5.
[10]曲淑芹.论类风湿关节炎证治特点[J].中国中医药信息杂志,2008,15(9):93.
[J].zhongguo zhongyiyao xinxi zazhi,2008,15(2):93.
备注/Memo
基金项目:国家中医药管理局资助项目(LP0117039);湖北省自然科学基金(2016CFB649);云南省教育厅科学研究基金项目(2017ZZX019);湖北省卫生厅科研基金资助项目([2008]614号);楚雄医专科研基金资助项目(2014XBYJ11)
更新日期/Last Update:
2019-02-15